News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
1–36
Matches
208
Sources here
23
Companies here
13
Search results Stored financial headlines

Active search

208 matching headlines

Ticker or company: DEMMain company stories
Clear

Renaissance Technologies LLC Purchases New Position in Tandem Diabetes Care, Inc. $TNDM

Renaissance Technologies LLC has acquired a new position in Tandem Diabetes Care, Inc. (NASDAQ:TNDM), purchasing 58,227 shares valued at approximately $1.12 million. Other institutional investors like Vanguard Group and Jennison Associates also increased their holdings. Tandem Diabetes Care reported mixed quarterly results with revenue …

TNDM main company
Sharemaestro market context Price above Trend Line 52 weeks +90.4% TNDM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

AlTi Global (ALTI) Stock Drifts As AUM Climbs Yet Losses Linger

AlTi Global's stock saw a slight increase after its Q2 2026 earnings report, with assets under management (AUM) rising to US$49.7 billion due to net inflows. Despite this growth in AUM, the company continues to report losses, with a basic loss per share of …

ALTI main company
Sharemaestro market context Price above Trend Line 52 weeks -7.6% ALTI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Demant AS (WILLF) (Q2 2026) Earnings Call Highlights: Strong H1 Growth Fueled by Oticon Zeal ...

This article first appeared on GuruFocus. Revenue Growth: Group reported growth of 15% in H1 2026, with 7% organic growth and 10% acquisitive growth, primarily from KIND. Gross Margin: Increased by 1.1 percentage points, driven by strong ASP in hearing aids and the acquisition …

DEMANT main company DEMA main company
Sharemaestro market context Trend signal active 52 weeks +15.8% DEMANT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Global Indemnity (GBLI) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Wed., Aug. 5, 2026 at 11 a.m. ET CALL PARTICIPANTS Chief Operating Officer - Evan KasowitzChief Executive - Jay BrownChief Financial Officer - Brian Riley TAKEAWAYS Net Income -- $11.1 million ($0.76 per share), compared to $10.3 million …

GBLI main company
Sharemaestro market context Price below Trend Line 52 weeks -4.0% · Next-week setup positive 55.9% GBLI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

TNDM Q2 Loss Narrower Than Expected, Revenues Miss, Stock Up

Tandem Diabetes Care (TNDM) reported a Q2 2026 loss of 31 cents per share, which was narrower than expected, though worldwide revenues of $254.6 million missed consensus estimates. Despite the revenue miss, the company's shares rose 19.1% after the announcement, driven by increased pump …

TNDM main company
Sharemaestro market context Price above Trend Line 52 weeks +90.4% TNDM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Tandem Diabetes Care, Inc. (TNDM) Investor Outlook: Analyzing 25% Potential Upside with No Sell Ratings

Tandem Diabetes Care, Inc. (TNDM) presents a high-risk, high-reward investment opportunity in the medical devices industry, with analysts projecting a 25% potential upside and no sell ratings. Despite current financial challenges like negative EPS and free cash flow, the company is bullishly positioned above …

TNDM main company
Sharemaestro market context Price above Trend Line 52 weeks +90.4% TNDM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

What is Zacks Research's Forecast for GBLI Q3 Earnings?

Zacks Research has lowered its Q3 2026 EPS forecast for Global Indemnity Group (GBLI) to $0.73 from $0.77, also projecting Q4 EPS of $0.59, with the full-year consensus at $2.68. This adjustment follows GBLI missing its recent quarterly earnings expectations with an EPS of …

GBLI main company
Sharemaestro market context Price below Trend Line 52 weeks -4.0% · Next-week setup positive 55.9% GBLI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Academy Sports and Outdoors (ASO) Short Interest & Short Float | Updated Aug 2026

This article provides an updated overview of Academy Sports and Outdoors (ASO) short interest data as of July 31, 2026. It details that ASO's short interest increased by 0.80% to 7.81 million shares, representing 13.13% of the public float, with a short interest ratio …

ASO main company
Sharemaestro market context Price below Trend Line 52 weeks -10.1% · Next-week setup positive 55.8% ASO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Academy Sports partners with Instacart for same-day delivery in as fast as one hour

Academy Sports & Outdoors has partnered with Instacart to provide same-day delivery services, with orders fulfilled in as fast as one hour. This collaboration expands Academy's omnichannel reach to over 300 stores across 21 states, allowing customers to access their full product assortment through …

ASO main company
Sharemaestro market context Price below Trend Line 52 weeks -10.1% · Next-week setup positive 55.8% ASO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

AM Best affirms Global Indemnity's A (Excellent) rating for 24th consecutive year.

AM Best has reaffirmed its A (Excellent) financial strength rating for Global Indemnity Group, LLC's U.S. insurance subsidiaries for the 24th consecutive year. This rating signifies the company's robust financial health, conservative investment practices, and consistent profitability in its specialty insurance sector. The affirmation …

GBLI main company
Sharemaestro market context Price below Trend Line 52 weeks -4.0% · Next-week setup positive 55.9% GBLI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Instacart and Academy Sports + Outdoors Team Up for Same-Day Delivery in as Fast as an Hour

Customers can now shop Academy's national and exclusive private brands across sports, outdoor, apparel, footwear and more at no markups SAN FRANCISCO and KATY, Texas, Aug. 10, 2026 /PRNewswire/ -- Instacart (Nasdaq: CART), the leading grocery technology company in North America, today announced a …

ASO main company
Sharemaestro market context Price below Trend Line 52 weeks -10.1% · Next-week setup positive 55.8% ASO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Zacks Research Has Pessimistic View of GBLI FY2026 Earnings

Zacks Research has lowered its FY2026 EPS forecast for Global Indemnity Group (NASDAQ:GBLI) to $2.37, falling short of the $2.68 consensus estimate, and projected FY2027 EPS at $2.96. This follows Global Indemnity reporting quarterly EPS of $0.59, missing analysts’ consensus of $0.63, despite revenues …

GBLI main company
Sharemaestro market context Price below Trend Line 52 weeks -4.0% · Next-week setup positive 55.9% GBLI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ALTI | AlTi Global, Inc. Class Financials - Income Statement

This page provides financial data and other information for AlTi Global, Inc. (ALTI). It includes sections on income statement, balance sheet, cash flow, institutional holdings, analyst ratings, and insider trading activity, but notes a lack of recent data for many categories. The company is …

ALTI main company
Sharemaestro market context Price above Trend Line 52 weeks -7.6% ALTI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Why Tandem Diabetes Care (TNDM) Is Up 14.8% After Reaffirming 2026 Outlook And Highlighting Mobi Momentum

Tandem Diabetes Care (TNDM) saw its stock rise 14.8% after reaffirming its full-year 2026 sales outlook of US$1.07–1.09 billion and highlighting early success with its Pay-As-You-Go pharmacy model and growing adoption of its Mobi platform. The company reported second-quarter sales of US$254.56 million and …

TNDM main company
Sharemaestro market context Price above Trend Line 52 weeks +90.4% TNDM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Why Tandem Diabetes Care (TNDM) Is Up 14.8% After Record Q2 Sales And PayGo Momentum

Tandem Diabetes Care (TNDM) saw its stock rise 14.8% after reporting record Q2 2026 worldwide sales of US$254.56 million, a higher gross margin, and a reduced net loss, while reaffirming its full-year sales guidance of US$1.07 billion. The company's new PayGo pharmacy model, which …

TNDM main company
Sharemaestro market context Price above Trend Line 52 weeks +90.4% TNDM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Tandem Diabetes Care (TNDM) Could Be 23% Below Fair Value After Q2 Results

Tandem Diabetes Care (TNDM) reported strong Q2 2026 results with record worldwide sales and reaffirmed full-year guidance, leading to a significant rally in its share price. Despite the recent gains, Simply Wall St. suggests that TNDM is still undervalued by 23.4%, with a fair …

TNDM main company
Sharemaestro market context Price above Trend Line 52 weeks +90.4% TNDM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context